title: -NH-dansyl isocolchicine exhibits a significantly improved tubulin-binding affinity and microtubule inhibition in comparison to isocolchicine by binding tubulin through its A and B rings.
abstract: Structure-activity relationship studies have established that the A and C rings of colchicine comprise the minimum structural feature necessary for high affinity drug-tubulin binding. Thus, colchicine acts as a bifunctional ligand by making two points of attachment to the protein. Furthermore, analogues belonging to the iso series of colchicine are virtually inactive in binding to tubulin and inhibiting microtubule assembly. In the present study, we found that the substitution of a hydrophobic dansyl group on the B-ring side chain (C7 position) of isocolchicine reverses the structural alterations at the C ring and the newly synthesized -NH-dansyl isocolchicine restores the lost biological activity of the compound. It inhibits microtubule assembly efficiently with an IC(50) value of 10 microM and competes with [(3)H]colchicine for binding to tubulin. Moreover, although -NH-dansyl colchicine binding to tubulin involves two steps, the -NH-dansyl isocolchicine-tubulin interaction has been found to occur via a one-step process. Also, the affinity constant of the -NH-dansyl isocolchicine-tubulin interaction is roughly only 3 times lower than that of the -NH-dansyl colchicine-tubulin interaction. These results suggest that the enhanced microtubule inhibitory ability of -NH-dansyl isocolchicine is therefore related to the affinity of the drug-tubulin interaction and not to any conformational changes upon binding tubulin. We also observed that the competition of -NH-dansyl isocolchicine with [(3)H]colchicine for binding to tubulin was dependent on the tubulin concentration. In conclusion, this paper for the first time indicates that a biologically active bifuntional colchicine analogue can be designed where the drug binds tubulin through its A and B rings, while the C ring remains inactive.
authors.affiliation: Department of Biochemistry, Bose Institute, Calcutta 700054, India.
authors.forename: Lalita
authors.initials: L
authors.lastname: Das
authors.forename: Ajit B
authors.initials: AB
authors.lastname: Datta
authors.forename: Suvroma
authors.initials: S
authors.lastname: Gupta
authors.forename: Asim
authors.initials: A
authors.lastname: Poddar
authors.forename: Suparna
authors.initials: S
authors.lastname: Sengupta
authors.forename: Mark E
authors.initials: ME
authors.lastname: Janik
authors.forename: Bhabatarak
authors.initials: B
authors.lastname: Bhattacharyya
mesh_terms: D001665:Binding Sites; D003078:Colchicine / Q000737:chemistry* / Q000378:metabolism*; D003619:Dansyl Compounds / Q000737:chemistry* / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D007536:Isomerism; D007700:Kinetics; D008024:Ligands; D008956:Models, Chemical; D008958:Models, Molecular; D008968:Molecular Conformation; D011485:Protein Binding; D011487:Protein Conformation; D011869:Radioligand Assay; D013050:Spectrometry, Fluorescence; D013329:Structure-Activity Relationship; D014316:Tritium / Q000378:metabolism; D014404:Tubulin / Q000378:metabolism*; D050257:Tubulin Modulators
chemical_list: D003619:Dansyl Compounds; D008024:Ligands; D014404:Tubulin; D050257:Tubulin Modulators; D014316:Tritium; C059352:isocolchicine; D003078:Colchicine